文献速递生殖医学妇科

经直肠超声引导取卵用于阴道癌患者

Transrectal approach to oocyte retrieval in a patient with vaginal cancer.
PubMed 文献 · Fertil Steril · 2026-10-30

视频文章描述一例19岁原发性阴道透明细胞癌处女患者,因疼痛和出血无法经阴道超声,采用经直肠超声引导取卵(TROR)。术后口服左氧氟沙星和甲硝唑5天,恢复顺利。

要点

  • 阴道癌患者无法经阴道检查时,TROR是可行的取卵替代路径。
  • TROR前需肠道准备,使用23.8mm直径阴道探头经直肠观察双卵巢。
  • TROR仅在经阴道、经腹或腹腔镜取卵不安全或不可行时考虑。

核心结论

  • TROR是阴道癌或宫颈癌患者经腹和/或腹腔镜取卵的可行替代方案。
  • TROR应仅在经阴道、经腹或腹腔镜取卵不安全或不可行时实施。

研究设计与样本

  • 视频文章,大学附属生殖中心,1例19岁原发性阴道透明细胞癌处女患者。
  • 患者因疼痛和出血无法耐受盆腔检查或经阴道超声。
  • 基础窦卵泡计数37,抗苗勒管激素67 pmol/L(9.38 ng/mL)。

主要发现

  • 控制性卵巢刺激采用GnRH拮抗剂方案,重组FSH 150单位启动。
  • 刺激第10天经腹超声见双卵巢11个卵泡≥17mm,仅能进入右卵巢外侧,左卵巢受子宫和血管限制。
  • 术后口服左氧氟沙星和甲硝唑5天,恢复顺利,不久开始肿瘤治疗。

关键数值与推荐

  • TROR使用7 mHz阴道探头(直径23.8mm),无菌套覆盖并充分润滑,经直肠置入。
  • 使用17 G、25cm单腔针行卵泡抽吸。

临床怎么用

  • 对阴道癌或宫颈癌需保留生育力且无法经阴道取卵者,可考虑TROR。
  • TROR前需肠道准备,术后预防性使用抗生素。
  • TROR应作为经阴道、经腹或腹腔镜取卵不可行时的备选方案。

局限性

  • 单例视频文章,经验有限。
  • TROR为新术式,需严格掌握指征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the pre-procedural planning and demonstrate the intra-procedural technique of transrectal ultrasound-guided oocyte retrieval (TROR) in a patient with vaginal cancer. DESIGN: Video article. SETTING: University-affiliated fertility center. SUBJECT(S): A 19-year-old virginal female with primary clear cell cancer of the vagina presented for fertility preservation. She was unable to tolerate a pelvic examination or transvaginal ultrasonography (TVUS) due to significant pain and bleeding. Her antral follicle count (AFC) and anti-mullerian hormone (AMH) was 37 and 67 pmol/L (9.38 ng/mL), respectively. Controlled ovarian stimulation (COS) was initiated with 150 units of recombinant follicle stimulating hormone (FSH) in a gonadotropin-releasing hormone (GnRH) antagonist protocol. Transabdominal ultrasonography (TAUS) on the 10th day of COS revealed 11 follicles measuring 17 mm or larger in both ovaries. TAUS also demonstrated access to only the lateral portion of the right ovary; access to the left ovary was limited significantly by the uterus and intervening vasculature. Given the short notice, a laparoscopic oocyte retrieval was not possible, and both transabdominal and transrectal retrieval of oocytes was proactively discussed. Bowel preparation was implemented the day before the retrieval. The patient gave consent for publication and posting of the video online including social media, the journal website, scientific literature websites (such as PubMed, ScienceDirect, Scopus, etc.) and other applicable sites. INTERVENTION: TROR 36 hours after ovulatory trigger. MAIN OUTCOME MEASURES: Total and mature oocyte yield after TROR. RESULTS: A 7 mHz vaginal transducer with diameter of 23.8 mm, covered with a sterile cover, and copious lubrication was gently introduced into the rectum. Both ovaries were visualized easily. A 17 G, 25-cm single lumen needle was used for follicular aspiration. Twenty nine oocytes were retrieved, of which 28 mature oocytes were cryopreserved. The patient was prescribed oral levofloxacin and metronidazole for 5 days post-TROR. She had an uneventful postoperative course and began her oncologic treatment shortly after. CONCLUSION: TROR is a viable alternative to the transabdominal and/or laparoscopic approach in patients with vaginal or cervical cancer. Despite its novelty, TROR should be performed only when transvaginal, transabdominal or laparoscopic oocyte retrieval is not safe or feasible.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Nathoo S, Lu B, Zhao K, et al. Transrectal approach to oocyte retrieval in a patient with vaginal cancer. Fertil Steril. 2026. PMID: 42962962. doi:10.1016/j.fertnstert.2026.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。